SweeGen announces successful scale-up of Reb N stevia sweetener
Stevia specialist SweeGen has commercialized Reb N, a lesser-known steviol glycoside “with a unique sensory profile… that makes it especially attractive for beverage applications.”
Rebaudioside N – which is found in trace quantities of the stevia leaf, making it difficult and expensive to isolate - is produced via SweeGen's patented ‘bioconversion’ process, which begins with stevia leaf extracts, and then uses enzymes* to convert them to specific target molecules (such as Reb I, D, M etc), said Shari Mahon, SVP of global application technology.
“Bestevia Reb N has a unique sweet profile that helps us create solutions that have a taste profile closer to both full-calorie and high intensity sweeteners. Our solutions are one of the most unique and tailored in the industry because of our access to the widest range of Rebs for sugar reduction.”
*from a genetically engineered yeast.
